Tirzepatide decreases systolic and diastolic blood pressure

Eur J Intern Med. 2023 Aug:114:135-137. doi: 10.1016/j.ejim.2023.04.005. Epub 2023 Apr 10.

Authors

Sidar Copur¹, Atalay Demiray¹, David Cherney², Katherine Tuttle³, Mehmet Kanbay⁴

Affiliations

¹ Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
² Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
³ Division of Nephrology, University of Washington, Seattle, WA, USA; Providence Medical Research Center, Providence Health Care, Washington, USA.
⁴ Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul 34010, Turkey. Electronic address: mkanbay@ku.edu.tr.

PMID: 37045710
DOI: 10.1016/j.ejim.2023.04.005

No abstract available

Publication types

Letter

MeSH terms

Blood Pressure
Diabetes Mellitus, Type 2*
Gastric Inhibitory Polypeptide
Humans
Hypertension* / drug therapy
Hypoglycemic Agents
Systole

Substances

tirzepatide
Gastric Inhibitory Polypeptide
Hypoglycemic Agents